Navigation Links
Sirnaomics and GRL Establish Partnership for the Development of Two Multi-Targeted RNAi Therapeutics Products
Date:3/12/2008

EEMNP) system for drug delivery in oncology. The company also has active programs in Whole-Genome siRNA Library (WGSL)-based high throughput screening for identification of novel drug targets and for re-invigoration of failed drugs in late stages of clinical testing, and has used this platform in the identification of RNAi therapeutic candidates for treatment of prostate cancer and improvement of wound healing. In addition, the company is actively engaged in the identification of optimal combination therapeutic regimens, including use of botanical drug candidates. GRL has strong scientific and clinical advisory boards and an experienced management team.

About Sirnaomics, Inc.

Sirnaomics, Inc. is a privately held Delaware corporation headquartered in Gaithersburg, Maryland, USA. Established by a group of leading scientists in the field of RNAi technology, the company has the mission of advancing RNAi technology for novel drug discovery and targeted therapeutics development. Members of the senior management team provide over 50 years of combined experience in the biopharmaceutical industry, finance and business management. This expertise will ensure the healthy growth of Sirnaomics as an international biopharmaceutical enterprise. The company is specialized in the development of nanoparticle-mediated nucleic acid delivery of multi-targeted siRNA therapeutics. In addition to the programs partnered with GRL, Sirnaomics is also developing siRNA cocktails against indications in ocular disease, influenza infection and additional indications in oncology. The name of the company Sirnaomics (/ser-'now-miks/) is derived from the tech word "siRNA" with the suffix "-omics" to signify the study of the structure and function of small interfering RNA including their silencing properties and complex interplay with the targeted sequences inside cells.


'/>"/>
SOURCE Sirnaomics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sirnaomics Received Multiple Government Fundings For Its Multi-Targeted siRNA Therapeutics Programs
2. Debiopharm and EPFL Establish an Oncology Chair
3. Ardea Biosciences Establishes Scientific Advisory Board for Inflammation Program
4. International Confocal Microscopy Working Group Established to Advance Practice of Reflective Confocal Microscopy
5. Rosetta Genomics Establishes Medical Advisory Board
6. Ardea Biosciences Establishes Scientific Advisory Board for HIV Program
7. Inverness - Chemogen Establish Exclusive License for TB Antibodies
8. Sureshield Coatings Company Established to Market Industry-Leading Portfolio of Advanced Coatings for Metal Surfaces
9. Sigma-Aldrich and the Universite de Montreal Establish Collaboration for RNA Interference Studies
10. Cellumen Establishes Collaboration in Breast Cancer Patient Stratification
11. KGI and Smith College Establish Leadership Forum for Women in Bioscience
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/16/2010)... Stock Exchange Symbol: MS , ... , , ... ... EDMONTON , March 16 ... ...
(Date:3/16/2010)... PharmAthene, Inc. (Amex: PIP ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results ... ... , ... ... ...
(Date:3/16/2010)... March 16 The Gynecologic Cancer Foundation (GCF) and the Claudia ... as the first recipient of the $50,000 GCF/Claudia Cohen Prize for Outstanding ... (SGO) 41st Annual Meeting on Women,s Cancer, meeting in San Francisco ... ... ...
(Date:3/16/2010)... (LSE: SHP,NASDAQ; SHPGY), announces that it has received a Paragraph IV Notice ... New Drug Application ("ANDA") for a generic version of Shire,s 1,mg, 2mg, ... ... ... , ...
Breaking Biology Technology:BioMS Medical Announces 2009 Year End Results 2BioMS Medical Announces 2009 Year End Results 3BioMS Medical Announces 2009 Year End Results 4BioMS Medical Announces 2009 Year End Results 5BioMS Medical Announces 2009 Year End Results 6BioMS Medical Announces 2009 Year End Results 7BioMS Medical Announces 2009 Year End Results 8BioMS Medical Announces 2009 Year End Results 9BioMS Medical Announces 2009 Year End Results 10PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010 2PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010 3Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 2Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 3Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 4Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 5Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals 2Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals 3Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals 4
... April 6 /PRNewswire/ - Orcrist Bio Inc. (ORC) ... today the approval of its Phase I, open-label, ... volunteers, by the European Competent Authority in Seville, ... assess the safety, tolerability, pharmacokinetics and pharmacodynamics (induction ...
... LLC announced today that it has issued an Executive ... CUR ). The full 56-page report can be ... or "the Company") is a biotherapeutics company using a ... central nervous system (CNS) diseases. The neurodegenerative conditions that ...
... - Program Focuses on Traumatic Brain Injury (TBI) and ... , Elsevier, the world-leading publisher of ... Foundation,announced today that it will Co-host the 6th Annual World ... at Harvard Medical,School , Boston, USA. , ...
Other Biology Technology:Orcrist Bio Inc. Receives Approval from European Competent Authority to Initiate its Planned Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Neuralstem, Inc. 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Neuralstem, Inc. 3Elsevier and Brain Mapping Foundation Co-Host 6th Annual World Congress of IBMISPS on Brain Mapping and Image Guided Therapy 2Elsevier and Brain Mapping Foundation Co-Host 6th Annual World Congress of IBMISPS on Brain Mapping and Image Guided Therapy 3Elsevier and Brain Mapping Foundation Co-Host 6th Annual World Congress of IBMISPS on Brain Mapping and Image Guided Therapy 4Elsevier and Brain Mapping Foundation Co-Host 6th Annual World Congress of IBMISPS on Brain Mapping and Image Guided Therapy 5Elsevier and Brain Mapping Foundation Co-Host 6th Annual World Congress of IBMISPS on Brain Mapping and Image Guided Therapy 6
(Date:3/18/2010)... can live for twenty years, fertilizing millions of eggs ... activity. , Danish researchers who have studied ants ... 1992 discovered that in both ant and bee species ... fluid favors the survival of its own sperm over ... stored, leafcutter ant queens neutralize male-male sperm competition with ...
(Date:3/18/2010)... available in Spanish . , Feeding ... as part of their regular diet makes them ... a study by Agricultural Research Service (ARS) scientists ... and overall behavioral activity among young female pigs ... acquired through diet, is the precursor for the ...
(Date:3/18/2010)... Biotech, Inc., ( www.genwaybio.com ) the US-based diagnostic company ... is expanding this cancer testing program internationally. An ... YouTM Cancer Assessment in Greece starting in April. ... as well. GenWay currently offers this test in ... Sergey Sikora, Vice President of Business Development, said, "The ...
Breaking Biology News(10 mins):Females shut down male-male sperm competition in leafcutter ants 2Tryptophan-enriched diet reduces pig aggression 2Moravia Worldwide Names George Krawczyk as Sales Director for Ireland and UK 61905 1Moravia Worldwide Names George Krawczyk as Sales Director for Ireland and UK 61905 2Barbara Fentress Designer of the Denver International Airport and Convention Center Offers Her Private Mansion at Absolute Auction 61902 1Barbara Fentress Designer of the Denver International Airport and Convention Center Offers Her Private Mansion at Absolute Auction 61902 2Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 1Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 2Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 3
... science responsible for species exploration and classification, has been ... a new International Institute for Species Exploration at Arizona ... is to spark a renaissance in taxonomy through a ... Quentin Wheeler, an entomologist and ASU vice president and ...
... occurred across the Eastern United States from 5 April to ... preceded by two weeks of unusual warmth, according to an ... authors of the report, Lianhong Gu and his colleagues at ... University of Missouri, and the National Oceanic and Atmospheric Administration, ...
... HONG KONG, Feb. 29 /Xinhua-PRNewswire/ -- Futronic ... software and hardware products,today announced that the ... Microsoft Vista and Windows 2008 Server., ... Windows,Logon control using proprietary fingerprint recognition technology. ...
Other Biology News:Species explorers ask: What's on Your planet? 2Species explorers ask: What's on Your planet? 3Will global warming increase plant frost damage? 2Futronic Announces Microsoft Vista and Windows 2008 Server Support for Its Fingerprint Logon Software 2
Ubiquitin Related I Sampler Kit 10 mu g each...
Chaperone Sampler Kit 10 mu g each...
Zonula Adherens Sampler Kit 10 mu g each...
Tumor Suppressor Sampler Kit 10 mu g each...
Biology Products: